Literature DB >> 2544990

Microvascular response to locally injected collagenase. An experimental investigation in hamsters and rabbits.

B Rydevik1, T Ehira, L Linder, K Olmarker, M Romanus, P I Brånemark.   

Abstract

Collagenase was injected into the ears of rabbits and the cheek-pouches of hamsters. The acute and long-term microvascular effects were studied by vital microscopy and microangiography. The enzyme was injected at three different concentrations: 120 units/ml, 600 units/ml and 3,000 units/ml. The medium (600 units/ml) and high (3,000 units/ml) concentrations induced effects on the microcirculation such as blood flow impairment and microbleedings. The magnitude of these effects was related to the concentration of the enzyme. Generally, these microvascular effects were of low magnitude as compared with other substances tested using the same experimental models.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544990     DOI: 10.3109/02844318909067503

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  6 in total

1.  Complications Following Collagenase Treatment for Dupuytren Contracture.

Authors:  Jennifer Wozniczka; Clifford Canepa; Adam Mirarchi; Joel S Solomon
Journal:  Hand (N Y)       Date:  2017-06-21

2.  [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].

Authors:  M Keller; R Arora; G Schmiedle; T Kastenberger
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

3.  Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis.

Authors:  Premsant Sangkum; Faysal A Yafi; Hogyoung Kim; Mostafa Bouljihad; Manish Ranjan; Amrita Datta; Sree Harsha Mandava; Suresh C Sikka; Asim B Abdel-Mageed; Krishnarao Moparty; Wayne J G Hellstrom
Journal:  Urology       Date:  2015-06-27       Impact factor: 2.649

4.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423

Review 5.  Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.

Authors:  Andrew T Gabrielson; Laith M Alzweri; Wayne Jg Hellstrom
Journal:  World J Mens Health       Date:  2017-09-06       Impact factor: 5.400

6.  Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease.

Authors:  Warren M Rozen; Yasith Edirisinghe; John Crock
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.